Asclepii Inc.

Asclepii Inc. is a US-based medical device company specializing in regenerative medicine and advanced wound care solutions. The company develops FDA-cleared nanosilver hydrogel wound dressings designed to support moisture balance and accelerate wound healing while preventing infection. Asclepii's flagship product, Poseidon™ Nanosilver Hydrogel, utilizes proprietary nanotechnology to deliver antimicrobial silver at ultra-low concentrations (1 ppm versus 30–10,000 ppm in competitors) without contributing to antibiotic resistance. Clinical studies demonstrate 96% infection-free outcomes within 8 days, outperforming leading silver dressings. The company serves clinics, providers, distributors, and resellers with scalable wound care technology designed for accessibility and clinical efficacy in everyday practice. Asclepii is developing next-generation bioengineered regenerative scaffolds for chronic and complex wound management.